Form D · Biotechnology
CalciMedica Subsidiary, Inc.
La Jolla, CA · CIK 0001385359
Offering snapshot reported Apr 4, 2023 · SEC filing
- Reported sold
- $10.3M Offering amount: $10.3M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2023 | Initial | $10,340,663 | No comparison | 8 | SEC filing |
| May 27, 2020 | Initial | $17,194,272 | No comparison | 12 | SEC filing |
| Apr 24, 2014 | Initial | $2,499,999 | No comparison | 5 | SEC filing |
| Jul 15, 2013 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
| Nov 5, 2012 | Initial | $4,600,000 | No comparison | 3 | SEC filing |
| Apr 2, 2012 | Initial | $13,200,000 | No comparison | 3 | SEC filing |
| Sep 29, 2011 | Initial | $4,000,000 | No comparison | 3 | SEC filing |
| Feb 8, 2011 | Amendment | $9,163,636 | $6,163,636vs Jul 22, 2010 | 6 | SEC filing |
| Jul 22, 2010 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
| Nov 6, 2009 | Initial | $9,000,000 | No comparison | 3 | SEC filing |
| Dec 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477889
Source: Form D, filed Apr 4, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lakmir Chawla | Director |
| Michael Diem | Director |
| Michael J. Dunn | Director, Executive |
| Brian Gallagher | Director |
| Daniel Geffken | Executive |
| Kent Gossett | Director |
| Vikas Goyal | Director |
| Evelyn Graham | Director |
| Sudarshan Hebbar | Executive |
| A. Rachel Leheny | Director, Executive |
| John Mc Donald | Director |
| Robert G. Mc Neil | Director |
| Peter Mc Williams | Director |
| Fred Middleton | Director |
| Eric W. Roberts | Executive |
| Kenneth A. Stauderman | Executive |
| Ken Stauderman | Executive |
| Gonul Velicelebi | Director, Executive |
| Robert Wilson | Director |
| Timothy Wollaeger | Director |
| Gordon Wong | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
505 Coast Boulevard South Suite 307
La Jolla, CA, 92037
La Jolla, CA, 92037